Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.
Name | Percentage | |
---|---|---|
Thorne | 91.7% | |
Gut Zoomer (vibrant-wellness) | 48.3% | |
Laboratorio Teletest | 45.8% | |
DayTwo | 29.2% | |
Genova Gi Effects (cfu/g) | 25% | |
Metagenomics Stool (De Meirleir) (16s Limited) | 25% | |
GanzImmun Diagnostic A6 (cfu/gm) | 23.3% | |
Diagnostic Solution GI-Map (cfu/gm) | 22.5% | |
Medivere Mikrobiom Plus Stuhlanalyse | 21.7% | |
Microbiome Healthpath Maxi | 21.7% | |
Tarmkollen Mega | 20% | |
Biovis Microbiome Plus (cfu/g) | 20% | |
GI360 Stool (UK) | 18.3% | |
Chuckling Goat | 17.5% | |
Nordic Laboratories | 15.8% | |
NutriPATH | 14.2% | |
Viome (Latest Reports Fail to provide ANY measurements) | 14.2% | |
InVitaLab (cfu/gm) | 11.7% | |
GI EcologiX (Invivo) | 10% | |
Bioscreen (cfu/gm) | 9.2% | |
GanzImmun Diagnostics AG Befundbericht | 9.2% | |
Medivere: Gesundsheitscheck Darm (16s Limited) | 9.2% | |
Medivere: Darn Magen Diagnostik (16s Limited) | 8.3% | |
Verisana (cfu/ml) aka (kbe/ml) | 8.3% | |
Estudio de Disbiosis: Intestinal + Parasitos | 8.3% | |
Biomefx | 8.3% | |
Kyber Kompakt (cfu/g) | 7.5% | |
Medivere: Darm Mikrobiom Stuhltest (16s limited) | 7.5% | |
Smart Gut (16s - Limited Taxonomy) | 7.5% | |
Genova Parasitology (cfu/g) | 4.2% | |
FASTQ processed thru both Thryve and BiomeSight | 0% |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.